1Abramson Cancer Center, Departments of 2Medicine, 3Cancer Biology, and 4Pathology and Laboratory Medicine, 5Basser Research Center for BRCA1/2, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania; 6Vironika, Philadelphia, Pennsylvania; 7Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital; 8Program in Cancer Genetics, Departments of Oncology and Human Genetics, and 9Research Institute, McGill University Health Centre, McGill University, Montreal, Quebec, Canada; 10Department of Medical Genetics, University of Cambridge, Cambridge; and 11Ferguson Smith Centre for Clinical Genetics, Yorkhill, Glasgow, United Kingdom; 12Cancer Epidemiology Program, H. Lee Moffitt Cancer Center, Tampa, Florida; 13Cancer Genetic Risk Assessment Program, Bryan Hemming Cancer Care Center, San Francisco, California; 14Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; 15Huntsman Cancer Institute and Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah
1Abramson Cancer Center, Departments of 2Medicine, 3Cancer Biology, and 4Pathology and Laboratory Medicine, 5Basser Research Center for BRCA1/2, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania; 6Vironika, Philadelphia, Pennsylvania; 7Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital; 8Program in Cancer Genetics, Departments of Oncology and Human Genetics, and 9Research Institute, McGill University Health Centre, McGill University, Montreal, Quebec, Canada; 10Department of Medical Genetics, University of Cambridge, Cambridge; and 11Ferguson Smith Centre for Clinical Genetics, Yorkhill, Glasgow, United Kingdom; 12Cancer Epidemiology Program, H. Lee Moffitt Cancer Center, Tampa, Florida; 13Cancer Genetic Risk Assessment Program, Bryan Hemming Cancer Care Center, San Francisco, California; 14Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; 15Huntsman Cancer Institute and Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah
1Abramson Cancer Center, Departments of 2Medicine, 3Cancer Biology, and 4Pathology and Laboratory Medicine, 5Basser Research Center for BRCA1/2, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania; 6Vironika, Philadelphia, Pennsylvania; 7Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital; 8Program in Cancer Genetics, Departments of Oncology and Human Genetics, and 9Research Institute, McGill University Health Centre, McGill University, Montreal, Quebec, Canada; 10Department of Medical Genetics, University of Cambridge, Cambridge; and 11Ferguson Smith Centre for Clinical Genetics, Yorkhill, Glasgow, United Kingdom; 12Cancer Epidemiology Program, H. Lee Moffitt Cancer Center, Tampa, Florida; 13Cancer Genetic Risk Assessment Program, Bryan Hemming Cancer Care Center, San Francisco, California; 14Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; 15Huntsman Cancer Institute and Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah
1Abramson Cancer Center, Departments of 2Medicine, 3Cancer Biology, and 4Pathology and Laboratory Medicine, 5Basser Research Center for BRCA1/2, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania; 6Vironika, Philadelphia, Pennsylvania; 7Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital; 8Program in Cancer Genetics, Departments of Oncology and Human Genetics, and 9Research Institute, McGill University Health Centre, McGill University, Montreal, Quebec, Canada; 10Department of Medical Genetics, University of Cambridge, Cambridge; and 11Ferguson Smith Centre for Clinical Genetics, Yorkhill, Glasgow, United Kingdom; 12Cancer Epidemiology Program, H. Lee Moffitt Cancer Center, Tampa, Florida; 13Cancer Genetic Risk Assessment Program, Bryan Hemming Cancer Care Center, San Francisco, California; 14Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; 15Huntsman Cancer Institute and Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah